Abortion access was a key issue in Pennsylvania and other battleground states. The Affordable Care Act receded into the political background, although voters in South Dakota approved a ballot measure that expanded Medicaid, leaving just 11 states that haven't done so.
Healthcare was not a major issue in the midterm elections, but access to abortion was and it appears to have been a decisive factor in several states in the closely contested election.
Voters in California, Michigan and Vermont passed reproductive freedom measures guaranteeing access to abortion yesterday while votes in Kentucky rejected the “No Right to Abortion in Constitution Amendment.”
According to polling done jointly the Kaiser Family Foundation and the Associated Press, 48% of voters in Pennsylvania said the overturning of the Roe v. Wade had a major impact on which candidates they supported in the election. The proportion was similar in other battleground states, including Georgia, Arizona and Nevada.
However, at the national level, only 9% of voters ranked abortion as the most important issue compared with 47% who ranked the economy as most important. Abortion also ranked behind immigration, which 9% of voters ranked as the most important issue.
In hotly contested Pennsylvania, John Fetterman, the Democrat and a supporter of abortion rights, defeated Mehmet Oz, the Republican who tried to stake out a middle-ground position on abortion. In the state’s gubernatorial election, Josh Shapiro, the Democrat, defeated Douglas Mastriano, the Republican, by a wide margin. Shapiro’s campaign emphasized abortion access. Mastriano is strongly opposed to abortion.
As of this 10:30 a.m. Eastern Time this morning, the U.S. Senate races in Georgia, Arizona and Nevada hadn’t been called, although the Democratic candidate in Arizona, incumbent Mark Kelly, was ahead by several percentage points and the incumbent in Georgia, Raphael Warnock, had a slight lead over Republican challenger Herschel Walker. In Nevada, the Republican, Adam Laxalt, had a lead of several percentage points over the incumbent Democrat, Catherine Cortez Masto.
The Affordable Care Act (ACA), which Republicans had vowed to “repeal and replace” and Medicare for All, which Vermont Sen. Bernie Sanders and other progressives have pushed for, did not figure prominently in the campaigns leading up to voting yesterday.
South Dakota was, though, an exception. Amendment D, which expanded Medicaid eligibility, was on the ballot. It passed by a comfortable, 56%- 44% margin. The success of that ballot measure means that there are now just 11 states that have not expanded Medicaid under the ACA.
Related: Medicaid Expansion Is on the Ballot in South Dakota
Other healthcare-related on ballots yesterday included Proposition 209 in Arizona, which adds protections against medical debt collection, and Legislative Referendum 131 in Montana, which classifies an embryo or fetus as a legal person with a right to medical care if it survives an abortion or delivery.
Arizona Voters approved the medical debt proposition by a wide margin. The secretary of state’s office showed it passing, 72% -28%, this morning.
Several news outlets were reporting this morning that with most of the votes counted, Montana voters had rejected the born-alive referendum by 52%-48% margin.
In this episode of the "Meet the Board" podcast series, Briana Contreras, Managed Healthcare Executive editor, speaks with Ateev Mehrotra, a member of the MHE editorial advisory board and a professor of healthcare policy and medicine at Harvard Medical School. Mehtrotra is also a hospitalist at the Beth Israel Deaconess Medical Center in Boston. In the discussion, Contreras gets to know Mehrotra more on a personal level and picks his brain on some of his research interests including telehealth, alternative payment models and price transparency.
Listen
Inflation Reduction Act: Reforms to Patient Cost-Sharing
September 18th 2023Lower out-of-pocket costs for patients might put upward pressure on drug prices, as manufacturers face less price sensitivity, note Matthew Majewski and Rhett Johnson of Charles River Associates. But they also note that upward pressure on price is likely to be limited to the inflation rate as any additional price increase would need to be paid back to CMS in the form of inflation rebates.
Read More
Spending climbed by 2.7% in 2021. In 2020, it soared by 10.3%, fueled by federal government spending in response to the pandemic. The blizzard of calculations of 2021 healthcare spending by CMS’ actuaries also provides further evidence that utilization of healthcare services bounced back in 2021.
Read More
Talking PIE, the Act, Before Thanksgiving
November 23rd 2022AMCP CEO Susan A. Cantrell spoke with Managed Healthcare Executive® about Preapproval Information Exchange (PIE) Act of 2022, which would allow drug manufacturers to share information about a drug with payers before the drug is approved. Cantrell says passage of the PIE Act would speed up patient access to new medications.
Read More
Inflation Reduction Act and the Impact on Pharmaceutical Pricing and Investment Decisions
November 21st 2022The reference to “maximum fair price” in the act bodes poorly for manufacturers and suggests more of a take-it-or-leave-it situation rather than a negotiation where clinical evidence would be the prevailing factor in determining price.
Read More